Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Serologically defined colon cancer antigen 3 (Antigen NY-CO-3)

 SDCG3_HUMAN             Reviewed;         435 AA.
Q96C92; A6NCP1; O60525; Q5SXN1; Q5SXN2; Q5SXN3; Q5SXN4; Q5SXN8;
Q6V704; Q9NVY5;
18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
18-MAR-2008, sequence version 3.
27-SEP-2017, entry version 119.
RecName: Full=Serologically defined colon cancer antigen 3;
AltName: Full=Antigen NY-CO-3;
Name=SDCCAG3;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANTS
GLN-304 AND MET-379.
Lin L., Yu R., Cao L., Ke R., Li H., Zhou G., Shen C., Zhong G.,
Xiao W., Li M., Yang S.;
Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
Li W.B., Gruber C., Jessee J., Polayes D.;
"Full-length cDNA libraries and normalization.";
Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15164053; DOI=10.1038/nature02465;
Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
Rogers J., Dunham I.;
"DNA sequence and analysis of human chromosome 9.";
Nature 429:369-374(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
ILE-428.
TISSUE=Skin;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 80-435 (ISOFORMS 1/3), AND
VARIANT GLY-176.
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[7]
NUCLEOTIDE SEQUENCE [MRNA] OF 221-412.
TISSUE=Colon carcinoma;
PubMed=9610721;
DOI=10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.0.CO;2-P;
Scanlan M.J., Chen Y.-T., Williamson B., Gure A.O., Stockert E.,
Gordan J.D., Tuereci O., Sahin U., Pfreundschuh M., Old L.J.;
"Characterization of human colon cancer antigens recognized by
autologous antibodies.";
Int. J. Cancer 76:652-658(1998).
[8]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in
signaling networks.";
Cell 127:635-648(2006).
[9]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18669648; DOI=10.1073/pnas.0805139105;
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=20068231; DOI=10.1126/scisignal.2000475;
Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
Mann M.;
"Quantitative phosphoproteomics reveals widespread full
phosphorylation site occupancy during mitosis.";
Sci. Signal. 3:RA3-RA3(2010).
[11]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-243, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma, and Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[12]
FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PTPN13 AND GIT1, AND
MUTAGENESIS OF PRO-190 AND GLU-194.
PubMed=23108400; DOI=10.1038/onc.2012.485;
Hagemann N., Ackermann N., Christmann J., Brier S., Yu F.,
Erdmann K.S.;
"The serologically defined colon cancer antigen-3 interacts with the
protein tyrosine phosphatase PTPN13 and is involved in the regulation
of cytokinesis.";
Oncogene 32:4602-4613(2013).
[13]
FUNCTION, INTERACTION WITH VPS35, AND SUBCELLULAR LOCATION.
PubMed=25278552; DOI=10.1242/jcs.156299;
McGough I.J., Steinberg F., Gallon M., Yatsu A., Ohbayashi N.,
Heesom K.J., Fukuda M., Cullen P.J.;
"Identification of molecular heterogeneity in SNX27-retromer-mediated
endosome-to-plasma-membrane recycling.";
J. Cell Sci. 127:4940-4953(2014).
[14]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-147 AND SER-243, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Liver;
PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
Wang L., Ye M., Zou H.;
"An enzyme assisted RP-RPLC approach for in-depth analysis of human
liver phosphoproteome.";
J. Proteomics 96:253-262(2014).
-!- FUNCTION: May be involved in modulation of TNF response. May be
involved in presentation of TNFRSF1A on the cell surface (By
similarity). Involved in the endosome-to-plasma membrane
trafficking and recycling of SNX27-retromer-dependent cargo
proteins, such as GLUT1 (PubMed:25278552). Involved in the
regulation of cytokinesis; the function may involve PTPN13 and
GIT1 (PubMed:23108400). {ECO:0000250|UniProtKB:A2AIW0,
ECO:0000269|PubMed:23108400, ECO:0000269|PubMed:25278552}.
-!- SUBUNIT: Interacts with PTPN13, GIT1, VPS35 (PubMed:23108400,
PubMed:25278552). {ECO:0000269|PubMed:23108400,
ECO:0000269|PubMed:25278552}.
-!- INTERACTION:
Q9BXS5:AP1M1; NbExp=3; IntAct=EBI-10178036, EBI-541426;
P26196:DDX6; NbExp=3; IntAct=EBI-10178036, EBI-351257;
O00560:SDCBP; NbExp=3; IntAct=EBI-10178036, EBI-727004;
P0C1Z6-2:TFPT; NbExp=3; IntAct=EBI-10178036, EBI-10178002;
-!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:A2AIW0}.
Midbody {ECO:0000269|PubMed:23108400}. Early endosome
{ECO:0000269|PubMed:23108400}. Recycling endosome
{ECO:0000269|PubMed:23108400}. Note=During cytokinesis colocalized
with PTPN13 at the midbody (PubMed:23108400). Colocalizes in a
WASHC2-dependent manner with the retromer CSC complex at endosomes
(PubMed:25278552).
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=4;
Name=1;
IsoId=Q96C92-1; Sequence=Displayed;
Name=2;
IsoId=Q96C92-2; Sequence=VSP_032177;
Name=3;
IsoId=Q96C92-3; Sequence=VSP_032176;
Name=4;
IsoId=Q96C92-4; Sequence=VSP_040477;
Note=No experimental confirmation available.;
-!- SIMILARITY: Belongs to the SDCCAG3 family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=BAA91607.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
Sequence=CAI13936.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
Sequence=CAI13942.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
Sequence=CAI13943.2; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AY349357; AAQ56721.1; -; mRNA.
EMBL; CR597452; -; NOT_ANNOTATED_CDS; mRNA.
EMBL; AL592301; CAI13936.1; ALT_SEQ; Genomic_DNA.
EMBL; AL592301; CAI13940.2; -; Genomic_DNA.
EMBL; AL592301; CAI13941.2; -; Genomic_DNA.
EMBL; AL592301; CAI13942.2; ALT_SEQ; Genomic_DNA.
EMBL; AL592301; CAI13943.2; ALT_SEQ; Genomic_DNA.
EMBL; CH471090; EAW88230.1; -; Genomic_DNA.
EMBL; CH471090; EAW88231.1; -; Genomic_DNA.
EMBL; BC014515; AAH14515.2; -; mRNA.
EMBL; AK001296; BAA91607.1; ALT_INIT; mRNA.
EMBL; AF039688; AAC18037.1; -; mRNA.
CCDS; CCDS43903.1; -. [Q96C92-4]
CCDS; CCDS43904.1; -. [Q96C92-1]
CCDS; CCDS6999.2; -. [Q96C92-2]
RefSeq; NP_001034796.1; NM_001039707.1. [Q96C92-1]
RefSeq; NP_001034797.1; NM_001039708.1. [Q96C92-4]
RefSeq; NP_006634.3; NM_006643.3. [Q96C92-2]
UniGene; Hs.94300; -.
ProteinModelPortal; Q96C92; -.
SMR; Q96C92; -.
BioGrid; 116021; 57.
IntAct; Q96C92; 45.
MINT; MINT-1375073; -.
STRING; 9606.ENSP00000349929; -.
iPTMnet; Q96C92; -.
PhosphoSitePlus; Q96C92; -.
BioMuta; SDCCAG3; -.
DMDM; 172045853; -.
EPD; Q96C92; -.
MaxQB; Q96C92; -.
PaxDb; Q96C92; -.
PeptideAtlas; Q96C92; -.
PRIDE; Q96C92; -.
DNASU; 10807; -.
Ensembl; ENST00000298537; ENSP00000298537; ENSG00000165689. [Q96C92-2]
Ensembl; ENST00000357365; ENSP00000349929; ENSG00000165689. [Q96C92-1]
Ensembl; ENST00000371725; ENSP00000360790; ENSG00000165689. [Q96C92-4]
GeneID; 10807; -.
KEGG; hsa:10807; -.
UCSC; uc004chi.4; human. [Q96C92-1]
CTD; 10807; -.
DisGeNET; 10807; -.
EuPathDB; HostDB:ENSG00000165689.16; -.
GeneCards; SDCCAG3; -.
HGNC; HGNC:10667; SDCCAG3.
HPA; HPA029303; -.
neXtProt; NX_Q96C92; -.
OpenTargets; ENSG00000165689; -.
PharmGKB; PA35597; -.
eggNOG; ENOG410IHIY; Eukaryota.
eggNOG; ENOG4111TAC; LUCA.
GeneTree; ENSGT00390000000560; -.
HOVERGEN; HBG058095; -.
InParanoid; Q96C92; -.
OMA; IRPAFMC; -.
OrthoDB; EOG091G0JQ8; -.
PhylomeDB; Q96C92; -.
TreeFam; TF335840; -.
ChiTaRS; SDCCAG3; human.
GenomeRNAi; 10807; -.
PRO; PR:Q96C92; -.
Proteomes; UP000005640; Chromosome 9.
Bgee; ENSG00000165689; -.
CleanEx; HS_SDCCAG3; -.
ExpressionAtlas; Q96C92; baseline and differential.
Genevisible; Q96C92; HS.
GO; GO:0005769; C:early endosome; IDA:UniProtKB.
GO; GO:0005768; C:endosome; IDA:UniProtKB.
GO; GO:0030496; C:midbody; IDA:UniProtKB.
GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
GO; GO:0032465; P:regulation of cytokinesis; IDA:UniProtKB.
GO; GO:1990126; P:retrograde transport, endosome to plasma membrane; IMP:UniProtKB.
InterPro; IPR026757; SDCCAG3.
PANTHER; PTHR31259; PTHR31259; 1.
1: Evidence at protein level;
Alternative splicing; Cell cycle; Cell division; Coiled coil;
Complete proteome; Cytoplasm; Endosome; Phosphoprotein; Polymorphism;
Protein transport; Reference proteome; Transport.
CHAIN 1 435 Serologically defined colon cancer
antigen 3.
/FTId=PRO_0000324285.
REGION 173 198 Required for interaction with PTPN13.
{ECO:0000269|PubMed:23108400}.
COILED 261 371 {ECO:0000255}.
MOD_RES 18 18 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 147 147 Phosphoserine.
{ECO:0000244|PubMed:24275569}.
MOD_RES 243 243 Phosphoserine.
{ECO:0000244|PubMed:20068231,
ECO:0000244|PubMed:23186163,
ECO:0000244|PubMed:24275569}.
MOD_RES 247 247 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
VAR_SEQ 1 58 Missing (in isoform 3).
{ECO:0000303|Ref.1}.
/FTId=VSP_032176.
VAR_SEQ 24 96 Missing (in isoform 4).
{ECO:0000303|Ref.2}.
/FTId=VSP_040477.
VAR_SEQ 75 97 Missing (in isoform 2).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_032177.
VARIANT 157 157 L -> V (in dbSNP:rs7047681).
/FTId=VAR_039687.
VARIANT 176 176 E -> G (in dbSNP:rs17851182).
{ECO:0000269|PubMed:14702039}.
/FTId=VAR_039688.
VARIANT 304 304 R -> Q (in dbSNP:rs3812577).
{ECO:0000269|Ref.1}.
/FTId=VAR_039689.
VARIANT 379 379 V -> M (in dbSNP:rs1131992).
{ECO:0000269|Ref.1}.
/FTId=VAR_039690.
VARIANT 428 428 V -> I (in dbSNP:rs17855450).
{ECO:0000269|PubMed:15489334}.
/FTId=VAR_039691.
MUTAGEN 190 190 P->A: Disrupts interaction with PTPN13.
{ECO:0000269|PubMed:23108400}.
MUTAGEN 194 194 E->A: Disrupts interaction with PTPN13.
{ECO:0000269|PubMed:23108400}.
CONFLICT 7 7 R -> H (in Ref. 4; AAH14515).
{ECO:0000305}.
CONFLICT 343 343 N -> T (in Ref. 1; AAQ56721).
{ECO:0000305}.
SEQUENCE 435 AA; 47961 MW; 03EBD9512232B5E3 CRC64;
MSGYQRRPGA TPLSRARSLA IPDAPAFYER RSCLPQLNCE RPHGRDLDSP FFGIRPAFMC
YVPSPVLASV GDTDFGYGKG KCSKQSPSGA HGTHFGDDRF EDLEEANPFS FREFLKTKNL
GLSKEDPASR IYAKEASRHS LGLDHNSPPS QTGGYGLEYQ QPFFEDPTGA GDLLDEEEDE
DTGWSGAYLP SAIEQTHPER VPAGTSPCST YLSFFSTPSE LAGPESLPSW ALSDTDSRVS
PASPAGSPSA DFAVHGESLG DRHLRTLQIS YDALKDENSK LRRKLNEVQS FSEAQTEMVR
TLERKLEAKM IKEESDYHDL ESVVQQVEQN LELMTKRAVK AENHVVKLKQ EISLLQAQVS
NFQRENEALR CGQGASLTVV KQNADVALQN LRVVMNSAQA SIKQLVSGAE TLNLVAEILK
SIDRISEVKD EEEDS


Related products :

Catalog number Product name Quantity
EIAAB37719 Antigen NY-CO-8,CCCAP,Centrosomal colon cancer autoantigen protein,hCCCAP,Homo sapiens,HSPC085,Human,SDCCAG8,Serologically defined colon cancer antigen 8
EIAAB37718 Cccap,Centrosomal colon cancer autoantigen protein,mCCCAP,Mouse,Mus musculus,Sdccag8,Serologically defined colon cancer antigen 8 homolog
E1628h ELISA kit Antigen NY-CO-3,Homo sapiens,Human,SDCCAG3,Serologically defined colon cancer antigen 3 96T
E1628h ELISA Antigen NY-CO-3,Homo sapiens,Human,SDCCAG3,Serologically defined colon cancer antigen 3 96T
U1628h CLIA Antigen NY-CO-3,Homo sapiens,Human,SDCCAG3,Serologically defined colon cancer antigen 3 96T
EIAAB44202 Antigen NY-CO-33,Homo sapiens,Human,SDCCAG33,Serologically defined colon cancer antigen 33,Teashirt homolog 1,TSH1,TSHZ1
EIAAB45482 Antigen NY-CO-16,Homo sapiens,Human,SDCCAG16,Serologically defined colon cancer antigen 16,U3 small nucleolar RNA-associated protein 14 homolog A,UTP14A
E6106h Human Serologically Defined Colon Cancer Antigen 1 96T
E6107h Human Serologically Defined Colon Cancer Antigen 1 96T
EH1858 Serologically defined colon cancer antigen 3 Elisa Kit 96T
E5544h Human Serologically Defined Colon Cancer Antigen 8 96T
201-20-5155 SDCCAG8{serologically defined colon cancer antigen 8}rabbit.pAb 0.2ml
201-20-5154 SDCCAG3{serologically defined colon cancer antigen 3}rabbit.pAb 0.2ml
201-20-5153 SDCCAG10{serologically defined colon cancer antigen 10}rabbit.pAb 0.2ml
CSB-EL020897BO Bovine Serologically defined colon cancer antigen 3(SDCCAG3) ELISA kit 96T
CSB-EL020899MO Mouse Serologically defined colon cancer antigen 8(SDCCAG8) ELISA kit 96T
CSB-EL020897MO Mouse Serologically defined colon cancer antigen 3(SDCCAG3) ELISA kit 96T
CSB-EL020899HU Human Serologically defined colon cancer antigen 8(SDCCAG8) ELISA kit 96T
CSB-EL020897HU Human Serologically defined colon cancer antigen 3(SDCCAG3) ELISA kit 96T
H0518 Serologically defined colon cancer antigen 3 (SDCCAG3), Human, ELISA Kit 96T
H0517 Serologically defined colon cancer antigen 3 (SDCCAG3), Bovine, ELISA Kit 96T
H0520 Serologically defined colon cancer antigen 8 (SDCCAG8), Human, ELISA Kit 96T
H0521 Serologically defined colon cancer antigen 8 (SDCCAG8), Mouse, ELISA Kit 96T
H0519 Serologically defined colon cancer antigen 3 (SDCCAG3), Mouse, ELISA Kit 96T
201-20-5152 SDCCAG1{Homo sapiens serologically defined colon cancer antigen 1}rabbit.pAb 0.2ml


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur